Timeline

Frédérique Michel

Group Leader

19 Jan 2022

project

(FR) Signatures microARNs cellulaires dans la sclérose en plaques -SEP-MIR

01 Jan 2021

publication

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.

20 Feb 2020

event

Department of Immunology seminar: Roberto Mallone, Benign islet autoimmunity and type 1 diabetes: lessons from CD8+ T cells

08 May 2019

publication

Expression of endogenous retroviruses reflects increased usage of atypical enhancers in T cells

27 Feb 2017

publication

Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors

15 Sep 2015

project

TYK2 variants in cytokine signaling and autoimmune diseases

14 Sep 2015

project

Cellular and molecular immunoprofiling of multiple sclerosis patients

14 Sep 2015

project

Role of IFN-I in the development of IL-10-producing CD4 T cells

15 Jul 2013

publication

Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells

28 Jan 2013

publication

Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent

30 Nov 2010

publication

T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cells

16 Oct 2006

publication

T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2

25 Aug 2005

publication

Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function

01 Dec 2003

publication

CD28-mediated co-stimulation: a quantitative support for TCR signalling

01 Apr 2003

publication

Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor

23 Dec 2002

publication

CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling

06 Aug 2002

publication

A little guide for advanced search:

Timeline

(FR) Signatures microARNs cellulaires dans la sclérose en plaques -SEP-MIR

Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.

Department of Immunology seminar: Roberto Mallone, Benign islet autoimmunity and type 1 diabetes: lessons from CD8+ T cells

Expression of endogenous retroviruses reflects increased usage of atypical enhancers in T cells

Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors

TYK2 variants in cytokine signaling and autoimmune diseases

Cellular and molecular immunoprofiling of multiple sclerosis patients

Role of IFN-I in the development of IL-10-producing CD4 T cells

Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells

Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent

T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cells

T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2

Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function

CD28-mediated co-stimulation: a quantitative support for TCR signalling

Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor

CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling

CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?